Naltrexone to reduce criminal activity (re-incarceration) and improve treatment outcomes in drug-using offenders |
Harm reduction |
opioids |
prison |
Trade-off between benefits and harms |
Psychosocial treatments for depression and substance use disorders |
Treatment |
co-morbidity |
dual-diagnosis patients |
Unknown effectiveness |
Syringe provision through pharamcies, vending machines and mobile vans to reduce HIV, HCV and injecting risk behaviour |
Harm reduction |
amphetamines, opioids |
PWID – people who inject drugs |
Unknown effectiveness |
Treatment of attention deficit hyperactivity disorder (ADHD) and substance use disorders in adolescents |
Treatment |
co-morbidity, not-drug specific |
dual-diagnosis patients |
Unknown effectiveness |
Non-pharmacological interventions for deprescribing benzodiazepines and Z-drugs |
Treatment |
prescription medicines |
|
Unknown effectiveness |
Shared decision-making tools to reduce substance use |
Treatment |
not-drug specific |
|
Unknown effectiveness |
Behavioural harm reduction interventions to reduce HIV risk outcomes in crack/cocaine users |
Harm reduction |
cocaine |
|
Unknown effectiveness |
Mentoring for preventing drug use in young people |
Prevention |
not-drug specific |
communities, young people |
Unknown effectiveness |
Family- or individual-level multiple risk behaviour interventions to prevent illicit drug use |
Prevention |
not-drug specific |
young people |
Unknown effectiveness |
Life skill and social influence–based interventions to reduce hard drug use |
Prevention |
opioids |
school |
Unknown effectiveness |
Primary care models to improve opioid use disorders outcomes |
Treatment |
opioids |
communities |
Unknown effectiveness |
Physical exercise to improve drug-related outcomes |
Treatment |
not-drug specific |
|
Unknown effectiveness |
Pharmacological treatments for personality and substance use disorders |
Treatment |
co-morbidity |
dual-diagnosis patients |
Unknown effectiveness |
Distribution of safer crack-use-paraphernalia to reduce crack-related harms |
Harm reduction |
cocaine |
|
Unknown effectiveness |
Positive youth development (PYD) interventions to reduce substance use |
Prevention |
not-drug specific |
communities, young people |
Unknown effectiveness |
Drug court programmes to improve employment outcomes |
Social reintegration |
not-drug specific |
prison |
Unknown effectiveness |
Family- or individual-level multiple risk behaviour interventions to prevent cannabis use |
Prevention |
cannabis |
young people |
Unknown effectiveness |
Universal school-based interventions to prevent multiple risk behaviours relating to alcohol, tobacco and drug use |
Prevention |
alcohol, cannabis, tobacco |
school |
Unknown effectiveness |
Standalone life skill-based interventions to reduce hard drug use |
Prevention |
opioids |
school |
Unknown effectiveness |
Pharmacological management of opium withdrawal |
Treatment |
opioids |
|
Unknown effectiveness |
Integrated care of infectious diseases and substance use disorders to improve infectious disease treatment outcomes |
Treatment |
alcohol, co-morbidity, not-drug specific, amphetamines, cannabis, cocaine, new psychoactive substances (NPS), opioids, prescription medicines, tobacco |
communities, dual-diagnosis patients, emergency department, ethnic minority, families, law enforcement, pregnant women, PWID – people who inject drugs, school, women, prison, young people, partygoers/nightlife |
Unknown effectiveness |
Police-based diversion measures to prevent drug use |
Harm reduction |
not-drug specific |
law enforcement |
Unknown effectiveness |
Opioid withdrawal with antagonists under minimal sedation to retain patients and reduce relapses |
Treatment |
opioids |
|
Unknown effectiveness |
Drug consumption rooms (DCRs) to reduce harms for homeless and vulnerably housed persons |
Harm reduction |
amphetamines, opioids |
PWID – people who inject drugs |
Unknown effectiveness |
Workplace-based interventions for the prevention and treatment of problematic substance use |
Prevention |
|
|
Unknown effectiveness |
Primary care behavioural interventions to prevent or reduce substance use in children and adolescents |
Prevention |
not-drug specific |
communities, young people |
Unknown effectiveness |
Psycho-social treatment (including contingency management) to improve crack-cocaine users employment conditions |
Social reintegration |
cocaine |
|
Unknown effectiveness |
Behavioural activation (BA) interventions to reduce substance use and depressive symptoms |
Treatment |
co-morbidity |
dual-diagnosis patients |
Unknown effectiveness |
Targeted school-level interventions to prevent multiple risk behaviours relating to alcohol, tobacco and drug use |
Prevention |
alcohol, cannabis, tobacco |
school |
Unknown effectiveness |
School-based generic prevention programs in preventing alcohol misuse in school-aged children up to 18 years of age |
Prevention |
alcohol |
school |
Unknown effectiveness |
Community interventions to reduce harms from alcohol and other drug use |
Prevention |
alcohol, not-drug specific, cannabis |
communities |
Unknown effectiveness |
Telemedicine-delivered treatment interventions for substance use disorders |
Treatment |
alcohol, opioids, tobacco |
communities, dual-diagnosis patients, emergency department, ethnic minority, families, law enforcement, pregnant women, PWID – people who inject drugs, school, women, prison, young people, partygoers/nightlife |
Unknown effectiveness |
School-based eHealth interventions to prevent risk behaviours |
Prevention |
not-drug specific |
young people |
Unknown effectiveness |
Opioid withdrawal for adolescent opioid users |
Treatment |
opioids |
young people |
Unknown effectiveness |
Needle and syringe programmes in prison to prevent HIV and HCV infection and reduce injecting risk behaviours |
Harm reduction |
opioids |
prison |
Unknown effectiveness |
Brief interventions delivered in general medical settings to reduce use and harms |
Treatment |
alcohol, cannabis |
|
Unknown effectiveness |
Occupation-based interventions to improve recovery outcomes |
Social reintegration |
|
|
Unknown effectiveness |
Cognitive-behavioural treatment (CBT) to reduce stimulant use |
Treatment |
amphetamines, cocaine |
|
Unknown effectiveness |
Employer-led interventions to reduce use and adverse effects |
Social reintegration |
not-drug specific |
|
Unknown effectiveness |
Family and individual-based interventions to prevent multiple risk behaviours relating to alcohol, tobacco and drug use |
Prevention |
alcohol, cannabis, tobacco |
families |
Unknown effectiveness |
School-based brief interventions to reduce substance use and delinquent-type behaviours |
Prevention |
alcohol, cannabis |
school |
Unknown effectiveness |
Neurostimulation techniques in the treatment of cocaine dependence |
Treatment |
cocaine |
|
Unknown effectiveness |
Assertive community treatment (ACT) for substance use disorders |
Treatment |
alcohol, co-morbidity, not-drug specific, amphetamines, cannabis, cocaine, new psychoactive substances (NPS), opioids, prescription medicines, tobacco |
communities, dual-diagnosis patients, emergency department, ethnic minority, families, law enforcement, pregnant women, PWID – people who inject drugs, school, women, prison, young people, partygoers/nightlife |
Unknown effectiveness |
Psychotherapy to improve mental and treatment outcomes in patients with comorbid bipolar and substance use disorders |
Treatment |
not-drug specific |
dual-diagnosis patients |
Unknown effectiveness |
Brief interventions in patients with comorbid substance use |
Treatment |
co-morbidity |
|
Unknown effectiveness |
Substitution treatment for adolescent opioid users |
Treatment |
opioids |
young people |
Unknown effectiveness |
Pub-watching schemes to reduce alcohol-related crime against property |
Prevention |
alcohol |
law enforcement, partygoers/nightlife |
Unknown effectiveness |
Opioid substitution treatment (OST) to prevent HIV and HCV in prison |
Harm reduction |
opioids |
prison |
Unknown effectiveness |
Therapeutic communities to improve treatment outcomes |
Treatment |
not-drug specific |
|
Unknown effectiveness |
Permanent supportive housing (specifically Housing First) to reduce harms |
Harm reduction, Social reintegration |
not-drug specific |
communities |
Unknown effectiveness |